Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-07-09, Stock:ABBV, The news for the past five days is as follows:
2019-07-01: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS3: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS4: Notable Monday Option Activity: ABBV, TTWO, MRNS.NEWS5: Notable Monday Option Activity: ABBV, TTWO, MRNS.NEWS6: 7 Stocks on Sale the Insiders Are Buying.NEWS7: 7 Stocks on Sale the Insiders Are Buying.NEWS8: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS9: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS10: Monday 7/1 Insider Buying Report: MDCO, ABBV.NEWS11: Monday 7/1 Insider Buying Report: MDCO, ABBV.NEWS12: Acquisition Improves the Outlook of Pfizer Stock.NEWS13: Acquisition Improves the Outlook of Pfizer Stock.NEWS14: Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval.NEWS15: Acquisition Improves the Outlook of Pfizer Stock.
2019-07-02: NEWS1: Is AbbVie a Buy?.NEWS2: Is AbbVie a Buy?.NEWS3: Is AbbVie a Buy?.NEWS4: Why This Gilead-AbbVie Rivalry Could Come To A Head In 2020.NEWS5: IBM Is Set to Join Exclusive Group of Dividend Aristocrats.NEWS6: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS7: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS8: Insiders Buy the Holdings of DLN ETF.NEWS9: Insiders Buy the Holdings of DLN ETF.NEWS10: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS11: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS12: AbbVie’s Allergan Acquisition Sowed Doubts on Wall Street. Some Analysts Are Coming Around..NEWS13: 3 Biotechs That Have Doubled This Year (Acquisition Next?).NEWS14: Gilead to Submit NDA for Inflammation Drug Filgotinib in '19.NEWS15: Gilead Surges in the Race for Next Big Anti-Inflammatory Drug.NEWS16: Patent panic gives green light to mega pharma deals.
2019-07-03: NEWS1: Two Dividend Payers That Beat the SP 500.NEWS2: VUG, ABBV, CELG, UPS: Large Inflows Detected at ETF.NEWS3: VUG, ABBV, CELG, UPS: Large Inflows Detected at ETF.NEWS4: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS5: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.NEWS6: Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up.NEWS7: Will the Pharma Space Witness More Mega-Merger Deals in 2H?.
2019-07-05: NEWS1: Top Stock Reports for Amazon, UnitedHealth & AbbVie.NEWS2: AbbVie Falls 3%.
2019-07-08: NEWS1: 3 Dividend Stocks Retirees Must Have in Their Portfolios.NEWS2: ObsEva Ends Recruitment in Second Uterine Fibroids Study.NEWS3: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS4: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS5: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS6: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS7: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.NEWS8: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.NEWS9: The Zacks Analyst Blog Highlights: Amazon, UnitedHealth, AbbVie, Simon Property and Autodesk.NEWS10: AbbVie (ABBV) Shares Down So Far This Year: Here's Why.NEWS11: Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice.

Answer: Rise